Doxorubicin (Adocia)

N/A

Report date: 2026/01/26 13:50:21

Base Information

Drug NameDoxorubicin (Adocia)
Drug Alias Nameanti-ovarian cancer therapy (Adocia)Doxorubicin
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionTopoisomerase II inhibitorsVirus DNA polymerase inhibitors
TargetsVirus DNA polymeraseTopoisomerase II
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdocia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdocia
Active IndicationsN/A
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A